Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer: Final Report of the OCUM Study

202365 citationsJournal Article

Authors

R. Ruppert · München Klinik Neuperlach

T Junginger · Johannes Gutenberg University Mainz

Rainer Kube · Carl-Thiem-Klinikum Cottbus

Joachim Straßburg · Klinikum im Friedrichshain

Andreas Lewin · Sana Klinikum Lichtenberg

J Baral · Städtisches Klinikum Karlsruhe

Christoph A. Maurer

Abstract

The findings support the avoidance of nCRT in low-risk patients and suggest that in high-risk patients, neoadjuvant therapy should be intensified to improve prognosis.

Topics & Keywords

Colorectal Cancer Surgical Treatments Colorectal and Anal Carcinomas Gastric Cancer Management and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 41, Issue 24, pp. 4025-4034

DOI: 10.1200/jco.22.02166

Field-Weighted Citation Impact: 14.96